IJAMCT LOGO

Informed Consent Policy

The International Journal of Advanced Medical and Clinical Therapeutics (IJAMCT) upholds stringent ethical standards in the conduct and reporting of research involving human subjects. The Informed Consent Policy mandates that authors obtain informed consent from all participants involved in their research and provide documentation of this consent in their manuscript. This policy is designed to ensure the ethical treatment of research participants, safeguard their rights, and maintain the integrity of the research process.

Requirement for Informed Consent:

  • Consent from Participants: Authors must obtain written informed consent from all human subjects who participate in their research. This consent must be secured prior to any research activities involving these individuals.

  • Informed Consent Process: The informed consent process involves providing participants with clear and comprehensive information about the nature, purpose, risks, benefits, and procedures of the research. Participants must be given the opportunity to ask questions and must voluntarily agree to participate without any coercion.

Documentation in Manuscript:

  • Consent Statement: Authors must include a statement in their manuscript confirming that informed consent was obtained from all participants. This statement should detail the process followed to ensure that participants were fully informed about the research and their involvement.

  • Ethics Committee Approval: In addition to the informed consent statement, authors must provide confirmation of approval from an appropriate ethics committee or institutional review board (IRB). This approval verifies that the research was conducted in accordance with ethical standards and regulatory requirements.

Ethical Treatment of Participants:

  • Rights and Welfare: The Informed Consent Policy emphasizes the protection of participants' rights and welfare throughout the research process. Authors must ensure that participants’ confidentiality is maintained, and that their personal information is handled with the utmost care.

  • Voluntary Participation: Participants must be informed that their involvement is voluntary and that they have the right to withdraw from the study at any time without penalty or loss of benefits.

Special Considerations:

  • Vulnerable Populations: Research involving vulnerable populations (e.g., minors, individuals with cognitive impairments) requires additional ethical considerations and protections. Authors must obtain consent from legally authorized representatives when necessary and ensure that all ethical guidelines are followed.

  • Consent Documentation: Authors should retain appropriate documentation of informed consent and ethics committee approval as part of their research records. This documentation should be available for review if required by the journal or regulatory bodies.

Compliance and Verification:

  • Compliance: Authors are responsible for ensuring compliance with the Informed Consent Policy and all applicable ethical guidelines. Failure to adhere to these requirements may result in delays in the review process or rejection of the manuscript.

  • Verification: IJAMCT reserves the right to request additional documentation or clarification regarding informed consent and ethics committee approval during the peer review process. Authors must be prepared to provide this information as needed.

Ethics and Integrity:

  • Commitment to Ethics: The Informed Consent Policy reflects IJAMCT’s commitment to maintaining the highest standards of research ethics and integrity. The journal supports the ethical conduct of research and the protection of human subjects as fundamental principles of scientific inquiry.

The Informed Consent Policy of IJAMCT underscores the importance of ethical practices in research involving human subjects. By requiring authors to obtain and document informed consent and ethics committee approval, the journal ensures that research is conducted with respect for participants' rights and welfare. This policy reinforces IJAMCT’s dedication to upholding ethical standards and contributing to the responsible advancement of medical and clinical knowledge.